Tu Whakaruruhau: The New Zealand Methamphetamine Treatment Evaluation Study

Not Applicable

Recruiting

• Conditions: Substance Dependence; Methamphetamine dependence; Mental Health - Addiction

• Registration Number: ACTRN12623000438651
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-01
• Last Update Posted: 21 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 320

Inclusion Criteria

Methamphetamine is the main drug of concern
Participants are aged 18 years of age or over
Participants have no severe cognitive disability that may affect their capacity to take part
Participants live in the Northland, Auckland, or Waikato regions of New Zealand.
Participants in the in-treatment-group will include those who have been admitted to treatment within the last two weeks of been screened for the study.
Participants in the Not-In-Treatment-Group [NITG] will include those who at the time of screening where not involved in formal treatment. NITG participants at screening will need to score 4 or more on the Severity of Substance Dependence Scale (SDS)

Exclusion Criteria

People who, in the last 30 days, have received any treatment for methamphetamine /amphetamine use, any in-patient drug treatment or imprisonment. NB: Participants in treatment will not be eligible to participate in this study if they received any treatment for methamphetamine /amphetamine use (any in-patient drug treatment or imprisonment, in the 30 days prior to starting the current treatment episode).

Study & Design

• Study Type: Observational
• Study Design: Not specified